NCT00002939View on ClinicalTrials.gov

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 1996

Primary Completion Date

February 28, 2001

Study Completion Date

April 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

irinotecan hydrochloride

DRUG

paclitaxel

Trial Locations (1)

60637

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00002939 - Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | Biotech Hunter | Biotech Hunter